BIEL IS THE NEXT BITCOIN! The Bitcoin ROI is abo
Post# of 8380
(Total Views: 123)
Posted On: 05/22/2025 7:11:19 PM
BIEL IS THE NEXT BITCOIN!
The Bitcoin ROI is about 40,000% over the past 10 years. BIEL will go viral at PPS = .006, which would generate massive press (free marketing/advertising) in the news and financial media when they report that the PPS increase is better than the gains in Amazon and Apple (3,000% over the past 10 years). It would solve all of BIEL's problems and create numerous opportunities for the company. The Reddit crowd would be all over it - generating more free online marketing/advertising - which could catapult the PPS to .04 (40,000% ROI on my .0001 shares)!
ACTIPATCH WILL BE A "STANDARD OF CARE" PRODUCT!
While Bitcoin has no underlying value (speculative bubble like abstract art or Dutch tulips in the 17th century), Actipatch has FDA clearances for the treatment of knee, back, wrist, hips, ankles, plantar fasciitis and all musculoskeletal pain. Actipatch has incredible value, especially at the low price of $35 - with a much longer battery life (720 hours or several months if extended with the on/off button) than the competition! The Actipatch FDA clearances allow it to be sold over the counter (without a prescription). The RecoveryRX applications (post operative pain, edema, wound care, etc.) require a doctor order. Add in RecoveryRx-Veterinary and you have over 10 billion potential repeat customers - every adult and pet on the planet - every month!
ENORMOUS POTENTIAL AS A "WELLNESS" PRODUCT!
People have successfully used Actipatch "off-label" for menstrual pain, migraine headaches, diabetic neuropathy, restless leg syndrome, opioid reduction, bladder issues, etc. There is also huge potential for prostate issues (non-cancerous), as there is evidence that PEMF/PSWT therapy helps with Benign Prostatic Hyperplasia (BPH) symptoms.
BIEL IS SIMPLE TO ANALYZE!
Q3 2021 was BIEL's only profitable quarter ($22,381) with $414,700 revenue (including $100k+ in covid relief funds). PROFITABILITY IS VERY CLOSE! Seems like $1.5 million annual revenue (or a $400k quarter) should do it, due to BIEL's extremely low operating costs and business model. Then the corresponding pps should hit .01 - and increase .01 for each additional $2.5 million annual revenue (P/E = 100). The $40 million tax-loss carry forward will make the first $40 million in profits tax free and accelerate the path to profitability.
The Bitcoin ROI is about 40,000% over the past 10 years. BIEL will go viral at PPS = .006, which would generate massive press (free marketing/advertising) in the news and financial media when they report that the PPS increase is better than the gains in Amazon and Apple (3,000% over the past 10 years). It would solve all of BIEL's problems and create numerous opportunities for the company. The Reddit crowd would be all over it - generating more free online marketing/advertising - which could catapult the PPS to .04 (40,000% ROI on my .0001 shares)!
ACTIPATCH WILL BE A "STANDARD OF CARE" PRODUCT!
While Bitcoin has no underlying value (speculative bubble like abstract art or Dutch tulips in the 17th century), Actipatch has FDA clearances for the treatment of knee, back, wrist, hips, ankles, plantar fasciitis and all musculoskeletal pain. Actipatch has incredible value, especially at the low price of $35 - with a much longer battery life (720 hours or several months if extended with the on/off button) than the competition! The Actipatch FDA clearances allow it to be sold over the counter (without a prescription). The RecoveryRX applications (post operative pain, edema, wound care, etc.) require a doctor order. Add in RecoveryRx-Veterinary and you have over 10 billion potential repeat customers - every adult and pet on the planet - every month!
ENORMOUS POTENTIAL AS A "WELLNESS" PRODUCT!
People have successfully used Actipatch "off-label" for menstrual pain, migraine headaches, diabetic neuropathy, restless leg syndrome, opioid reduction, bladder issues, etc. There is also huge potential for prostate issues (non-cancerous), as there is evidence that PEMF/PSWT therapy helps with Benign Prostatic Hyperplasia (BPH) symptoms.
BIEL IS SIMPLE TO ANALYZE!
Q3 2021 was BIEL's only profitable quarter ($22,381) with $414,700 revenue (including $100k+ in covid relief funds). PROFITABILITY IS VERY CLOSE! Seems like $1.5 million annual revenue (or a $400k quarter) should do it, due to BIEL's extremely low operating costs and business model. Then the corresponding pps should hit .01 - and increase .01 for each additional $2.5 million annual revenue (P/E = 100). The $40 million tax-loss carry forward will make the first $40 million in profits tax free and accelerate the path to profitability.
(3)
(0)